NIH-funded research R01 grant

Improving HIV treatment adherence for stimulant-using men

Official title: Supporting Treatment Adherence for Resilience and Thriving (START): A mHealth intervention to improve ART adherence for HIV-positive stimulant-using men

Funded at Florida International University · NIH-10898254 · Data updated 2026-11-12

This study is testing a new mobile health program called START to help HIV-positive men who use stimulants, like methamphetamine, stick to their treatment and improve their health over six months, while also checking how well it works over a year.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionFlorida International University
NIH-funded
Lab location1 site (Miami, United States)
Project startAugust 1, 2023
Project endJuly 31, 2025
Funding year2023
Award (this year)$109,548
NIH project number3R01DA049843-05S1
Project IDNIH-10898254 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are HIV-positive men who use stimulants and may struggle with adhering to their treatment regimens.

Less likely to help

Patients who do not use stimulants or are not HIV-positive are unlikely to benefit from this research.

What this research studies

This research focuses on enhancing adherence to antiretroviral therapy (ART) among HIV-positive men who use stimulants, particularly methamphetamine. It employs a mobile health (mHealth) intervention called START, which combines two evidence-based behavioral strategies to support patients in managing their HIV treatment. The study will involve a randomized controlled trial with 350 participants, comparing the effectiveness of the START intervention against a control group receiving standard information and resources. The primary goal is to improve viral load suppression within six months and assess the sustainability of these improvements over a year.

Why it matters

Potential benefit: If successful, this research could lead to better health outcomes for HIV-positive stimulant users by improving their treatment adherence and reducing viral loads.

How similar studies have gone: Previous research has shown promise in using behavioral interventions to improve treatment adherence among similar populations, indicating that this approach may be effective.

Where this research is happening

  • Florida International University
    Miami, United States
    Active

Researchers

  • Principal investigator: Carrico, Adam Wayne — Florida International University
  • Study coordinator: Carrico, Adam Wayne

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.